372 related articles for article (PubMed ID: 26102214)
21. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
Deeb KK; Trump DL; Johnson CS
Nat Rev Cancer; 2007 Sep; 7(9):684-700. PubMed ID: 17721433
[TBL] [Abstract][Full Text] [Related]
22. Calcitriol in cancer treatment: from the lab to the clinic.
Beer TM; Myrthue A
Mol Cancer Ther; 2004 Mar; 3(3):373-81. PubMed ID: 15026558
[TBL] [Abstract][Full Text] [Related]
23. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ
Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
25. Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways.
Ji Y; Wang X; Donnelly RJ; Uskokovic MR; Studzinski GP
J Cell Physiol; 2002 May; 191(2):198-207. PubMed ID: 12064463
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy.
Abu El Maaty MA; Wölfl S
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29048387
[TBL] [Abstract][Full Text] [Related]
27. 20-Epi-vitamin D3 analogs. Potent modulators of proliferation and differentiation of breast cancer cell lines in vitro.
Elstner E; Heber D; Koeffler HP
Adv Exp Med Biol; 1996; 399():53-70. PubMed ID: 8937548
[TBL] [Abstract][Full Text] [Related]
28. Studies on the influence of vitamin D3 metabolites on apoptosis induction in human neoplastic cells.
Gruber BM; Anuszewska EL
Acta Pol Pharm; 2003; 60(5):363-6. PubMed ID: 15005419
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.
Kawa S; Yoshizawa K; Nikaido T; Kiyosawa K
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):173-7. PubMed ID: 16039115
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress, cell cycle arrest and differentiation contribute toward the antiproliferative action of BSO and calcitriol on Caco-2 cells.
Liaudat AC; Bohl LP; Tolosa de Talamoni NG; Maletto B; Pistoresi-Palencia MC; Picotto G
Anticancer Drugs; 2014 Aug; 25(7):810-8. PubMed ID: 24681551
[TBL] [Abstract][Full Text] [Related]
31. Molecular link between vitamin D and cancer prevention.
Moukayed M; Grant WB
Nutrients; 2013 Sep; 5(10):3993-4021. PubMed ID: 24084056
[TBL] [Abstract][Full Text] [Related]
32. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells.
Galbiati F; Polastri L; Thorens B; Dupraz P; Fiorina P; Cavallaro U; Christofori G; Davalli AM
Endocrinology; 2003 May; 144(5):1832-41. PubMed ID: 12697689
[TBL] [Abstract][Full Text] [Related]
34. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.
Flynn G; Chung I; Yu WD; Romano M; Modzelewski RA; Johnson CS; Trump DL
Oncology; 2006; 70(6):447-57. PubMed ID: 17237620
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene.
Xu HM; Tepper CG; Jones JB; Fernandez CE; Studzinski GP
Exp Cell Res; 1993 Dec; 209(2):367-74. PubMed ID: 8262155
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological effects of vitamin D and its analogs: recent developments.
Sintov AC; Yarmolinsky L; Dahan A; Ben-Shabat S
Drug Discov Today; 2014 Nov; 19(11):1769-1774. PubMed ID: 24947685
[TBL] [Abstract][Full Text] [Related]
38. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
[TBL] [Abstract][Full Text] [Related]
39. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
40. Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
Wietrzyk J; Chodyński M; Fitak H; Wojdat E; Kutner A; Opolski A
Anticancer Drugs; 2007 Apr; 18(4):447-57. PubMed ID: 17351397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
